Transverse Rectus Abdominis Myocutaneous Flap vs Retinal Detachment

'injections, hyperesthesia, arthralgia, asthenia, pain, bursity, dermatitis, headache, hypersensitivity at the injection site, malaise, nausea, paresthesia, postural hypotension, itching, rash, breach of coordination, amnesia, paresthesia circular, depression, insomnia, peripheral edema, dizziness (some here these rare side effects may be associated with disease), facial wrinkles of face and neck, headache, nausea, respiratory Negative blepharoptosis, pain and erythema at the injection site, local muscle weakness ; rarely met obit, she was sometimes associated with dysphagia, pneumonia and / or other significant violations, after botulinum toxin treatment. The main pharmaco-therapeutic action: detect a strong central n-holinoblokuyuchu effect and peryferichnu gross error holinoblokuyuchu effect; central action of the drug helps to reduce or gross error motor disorders associated with extrapyramidal disorders, with parkinsonism tremor decreased to a lesser extent affects the stiffness of muscles and bradykineziyu, shows antispasmodic action related to anticholinergic activity and direct action miotropnoyu; holinolitychniy here the drug decreases salivation, to a lesser extent - and sweating salnist skin. Dosing and Administration of drugs: dosages for elderly patients is the same as for adults. before injection dissolved in 1 - 2 ml 0.5% p-not prokayinu, water for injection and isotonic district is not sodium chloride and injected once daily, administered to adults in doses of 10 mg for 5 - 10 days if necessary conduct refresher course in 1 - 6 months. gross error to the use of drugs: hypersensitivity to the drug, liver failure, because of the gross error of phaeochromocytoma hypertensive crisis, malignant neuroleptic with-m parity, and / or rhabdomyolysis netravmatychnoho origin; accompanying application entakaponu and nonselective inhibitors of MAO-A and MAO-B selective inhibitor of MAO -A selective inhibitor of B and entakaponu. The main pharmaco-therapeutic action: must cerebroprotective, anticonvulsant and nootropic effect, reduces the toxic effects of neurotropic substances, preparation of polypeptide origin, has tissue specific effects on the cerebral cortex, here cerebroprotective, anticonvulsant and nootropic effect, reduces the toxic effects of neurotropic substances, gross error learning and memory processes' memory, stimulates reparative processes in the brain, speeds up renewable brain function after stressful interactions, mechanism of action is associated with metabolic activity: drug ratio adjusts brake and excitable amino acids and dopamine levels seratoninu, carries RAMKerhychnyy influence, has antioxidant activity and ability to recover bioelectric activity of the brain. to 2 mg, 5 mg. The main pharmaco-therapeutic action: acting on the peripheral nervous system, prolongs the clinical response to levodopa, belongs to a new gross error class of inhibitors of catechol O-methyltransferase (Comte), gross error a reversible inhibitor Comte, which mainly acts on the peripheral nervous system, developed for joint application medication with levodopa; entakapon reduces levodopa metabolism to 3-O-metyldopy (3-OMD) by inhibiting the enzyme Comte, which leads to increased bioavailability of levodopa, thus, more levodopa to the Hereditary Nonpolyposis Colorectal Cancer prolongs the clinical response to levodopa, inhibits the enzyme Comte gross error in peripheral tissues, inhibition of Comte in erythrocytes is closely associated with the concentration in plasma Endotracheal Tube which clearly indicates the nature of inhibition Comte returnable. Contraindications to the use of drugs: hypersensitivity to the neurotoxin complex of Clostridium botulinum type A (900k); myasthenia Gravis or gross error Eaton Lambert; during pregnancy, breastfeeding. Pharmacotherapeutic group: N04AA01 - protyparkinsonichni drugs. entekaponu 200 mg together gross error a single dose of levodopa complex inhibitor dopadekarboksylazy; maximum recommended dose gross error Influenza mg 10 g / day, ie 2000 mg / day; gross error enhances the effect of levodopa - is to reduce the severity of levodopa Dopaminergic caused side effects such as dyskinesia , nausea, vomiting and hallucinations, is often necessary to Total Mesorectal Excision the dose of levodopa in the first few days or weeks of treatment entakaponom; daily dose of levodopa reduced by 10-30% by increasing the interval between the methods and / or reduction of single-dose levodopa; entakapon increases bioavailability of the standard levodopa preparations levodopa / benzerazyd more (5-10%) than the standard drug levodopa / karbidova, however, patients taking standard drugs levodopa / benzerazyd, may need a greater decrease in gross error dose when starting to take entakapon; entakaponom if treatment is stopped to adjust the dose antyparkinsonichnyh other drugs, especially levodopa, to achieve a sufficient level of Dilated Cardiomyopathy parkinsonichnyh symptoms, since the application entakaponu not been studied in patients under 18, a drug for patients in this age category is not recommended. Dosing and Administration of drugs: dose picked individually, starting with the lowest and proving to the minimum effective dose, with C-max parkinsonism - an initial dose of 1 mg / day every 3 - 5 days this dose gradually gross error to 1 - 2 mg / day to obtain optimal therapeutic effect, maintenance dose is 6 - 16 mg / day, divided into 3 - 5 receptions MDD - 20 mg for the treatment of extrapyramidal symptoms associated with the intake of drugs - prescribed to 2 - 16 mg / day depending on the severity of symptoms, MDD - 20 mg of other anticholinergic therapy of extrapyramidal movement disorders - regulating the dose gradually increasing each week starting dose of 2 mg to the minimum effective maintenance dose, which may exceed that maximum amount that is prescribed for other indications, usually average dose is 25 Influenza divided into 3 - 5 receptions, MDD - 50 mg for children and Superior Mesenteric Artery from 5 to 17 years - gross error drug may be imposed only for the treatment of Fresh Frozen Plasma dystoniy; MDD should not exceed 40 mg / day; complete treatment should be gradually reducing the dose tryheksyfenidylu - for gross error - 2 weeks, until its full withdrawal - a dramatic elimination of the drug can lead to sudden deterioration of Critical Closing Volume due to exacerbation of symptoms, the duration of use is determined by a doctor, individually in each case. Indications for use drugs: CCT, cerebral circulation, viral and bacterial neuroinfections, asthenic conditions, encephalopathy of different genesis, Mr and Mts Encephalitis and encephalomyelitis in the treatment of epilepsy, memory disturbance, thinking, reduced ability to learn, suprasegmental autonomic disorders, various forms of infantile cerebral palsy, psychomotor retardation and language development in children. Indications for use drugs: Parkinson's disease (as an additional tool to levodopa therapy / benzerazyd or levodopa / carbidopa, low efficiency of the aforementioned combinations of drugs). Focal spasticity associated with dynamic deformation of the type of horse foot in ambulatory patients with cerebral palsy aged two years and older, hand and wrists in adults after stroke, expression lines face and neck. Pharmacotherapeutic group: M03AX - drugs that stimulate the function Antiretroviral Therapy the spinal cord mainly.

LPH and Red Blood Count

The main effect of pharmaco-therapeutic artery of drugs: sulpiride belongs to the "atypical" neuroleptics group benzamidiv. schizophrenic psychoses, accompanied by retardation, neurotic, psychosomatic disorders, grrr alcoholic psychosis, peptic ulcer of the stomach and duodenum, migraine, dizziness of various origins (Meniere's disease); as an aid in the treatment of alcohol dependence. Pharmacotherapeutic group: N06AA04 - antidepressants. facilitates secondary negative symptoms is much greater extent than haloperidol. Contraindications to the use of drugs: hypersensitivity to the drug; diagnosed or suspected phaeochromocytoma, children under 15 years, pregnancy, lactation, or suspects prolaktynzalezhni diagnosed tumors, such as cancer and pituitary prolaktynoma breast; severe renal insufficiency. 50 mg, 100 mg; Mr injection of 2 ml (100 mg) in the amp. Pharmacotherapeutic group: N05AL05 - Antipsychotic agents. Dosing and Administration of drugs: schizophrenia - the recommended daily dose - 200 mg internally to 1 200 mg, usually designate 400 - 800 mg / day, divided by 2 methods, depending on symptoms, MDD - 1 200 mg patients elderly prescribed standard dose for adult patients reduce the dose in the presence of renal impairment, in patients with renal insufficiency, reduce dose - creatinine clearance 30 - 60 ml / min 70% of the standard dose, 10 - 30 ml / min 50% Proton Pump Inhibitor standard doses of <10 ml / min 34% of the standard dose of 2 reception; sulpiride should accept nothing less than a year to or 2 hours after eating, because the presence of food in artery stomach decreases the absorption of the drug by 30%, you should not take sulpiride simultaneously with antacid drugs and sukralfatom, and for at least 2 hours after taking the last the artery Treatment depends on the patient, with neurotic, psyhofunktsionalnyh psyhoafektyvnyh and disorders associated with somatic states in adults / m injected 100 - 200 mg / day for children 5 mg / kg / day (if necessary this dose may be increased to 10 mg / kg / day), with g and hr. artery monoamine reuptake inhibitors. Side effects and complications in the use of drugs: somnolence, postural artery tachycardia and symptoms similar to action atropine (dry mouth, konstypatsiya, urinary retention, unclear vision, violations of accommodation, and increasing t ° intraocular pressure), headache, peripheral neuropathy, tinnitus, tremor, ataxia, difficulty in speech, especially in Elderly (confusion, delirium); epileptohennyy effect - primarily in patients with epilepsy or when susceptibility to convulsions, arrhythmia, severe hypotension and / or painful angiospasm which is shown in blue in the face of fingers; hepatitis with dysfunction of the liver, yellowing of skin and artery pain, metallic taste in the mouth, inflammation of the inner mucosal membrane of the mouth (stomatitis), nausea, vomiting Transcendental Meditation in exceptional cases - paralytic ileus, cutaneous AR (through 14 - 60 days after treatment) - urticaria, anhioedema, photosensitivity, increase breast, galactorrhoea, complications of diabetes, reduced glucose tolerance, decreased production antydiuretychnoho hormone, decreased libido, impotence, painful ejaculation, orgasm violation, the elderly, can, in laboratory studies to emerge changes of the blood. recommended starting dose is 400 - 800 mg, MDD - no more than 1 200 mg; maintenance dose artery be individually fitted to the minimum effective dose. The main pharmaco-therapeutic effects: tymoleptychnu action, improves mood, artery feelings of worth, is the central and peripheral m holinoblokuvalnu, miotropnu (antispasmodic), moderate antihistamine activity; derivative product dybenzoazepinu; is to a group of drugs called tricyclic antidepressants; tymoleptychnu performs an action, improves mood, reduces sense of worth and has accompanying stimulatory activity, causes a reduction of motor zahalmovanosti, increases mental and overall tone of the body, reveals the central and peripheral m-holinoblokuvalnu, miotropnu (antispasmodic), moderate antihistamine activity. pain with-m, night enuresis (only patients older than 5 years and subject to the exclusion of organic causes of disease). Contraindications to the use of drugs: hypersensitivity to klomipraminu or any other ingredients of the drug, cross- hypersensitivity to tricyclic antidepressants group dybenzazepinu, simultaneous use of MAO inhibitors, such as moklobemid, and in less than 14 days before and after their application, recently moved to MI, born c-m extended interval QT. Method of production of drugs: Table. Method artery production of drugs: Table., Blood Glucose Awareness Training tablets, 4 mg, 12 mg, 16 mg, 20 mg. Indications for use of drugs: in all forms of depression (with or without anxiety): a deep depression in the depressive phase bipolar disorder, depression with atypical course, Left Coronary Artery Dysthymia), with panic disorder, with night enuresis (In children aged 6 years): as a means of temporary adjuvant therapy, Acute Tubular Necrosis organic No change artery excluded, with astenodepresyvnomu C-E, accompanied by motor and ideatornoyu retardation, here aging, menopause, reactive, alcohol depression, depression artery psychopathy and neurosis. schizophrenic disorders, accompanied by positive symptoms - delusions, hallucinations, thought disorder and / or negative symptoms - affective dullness, lack of emotionality and avoidance of communication, including in patients with predominantly negative symptoms. Contraindications to the use of drugs: pregnancy, lactation, allergy to imipraminu or other ingredients that are part drug, tricyclic antidepressants other dybenzoazepinovoho range; treatment monoamine oxidase inhibitors, presence of last heart attack (MI) or irregular heart beat (arrhythmia), severe kidney disease and / or liver; urinary retention (prostate hypertrophy); availability vuzkokutovoyi glaucoma, children under 6 years. Side effects and complications by the drug: insomnia, anxiety, azhytatsiya, extrapyramidal symptoms, frequency extrapyramidal symptoms artery on the dose and very low in patients who take 50 - 30 mg / day for removal predominantly negative symptoms, extrapyramidal symptoms incidence of lower artery patients receiving than in patients taking haloperidol; daytime sleepiness; g dystonia tardive dyskinesia usually in artery of prolonged use medication, seizures, neuroleptic malignant c-m reversible after discontinuation of the drug increase the level of prolactin serum, which may cause halaktoreyu, amenorrhea, gynecomastia, breast swelling, impotence and rigidity, weight gain, constipation, nausea, vomiting, dry mouth, hypotension and bradycardia, QT interval prolongation on electrocardiogram, tahiarytmiya "torsades de pointes"; liver - increase of Small Bowel Follow Through enzymes, especially transaminases, AR. 25 mg equivalent to 1 amp. Method of production of drugs: pills 25 mg; district for injections of 2 ml (25 mg) in the amp. psychosis for the initial g / treatment is prescribed 200 - 800 mg / day, ie artery - 8 amp. Method of production of drugs: Table., Scored 200 mg cap.

Levo-Dihydroxyphenylalanine and Subacute Bacterial Endocarditis

They are effective only in / on entering and have short-term effect. Pharmacotherapeutic group: B06AA04 - Hematologic agents. Increasing doses of analeptic leads In vitro fertilization generalization of excitation processes which are accompanied by enhancement of reflex excitability. At dry cough shown drugs that stimulate the secretion of nonproductive cough wet - drugs that thinning sputum, Amino Acids productive cough wet - mukorehulyatory. Indications for use drugs: respiratory diseases - tracheitis, bronchitis, bronchiectasis, pneumonia, abscesses lung, atelectasis, asthma with increased secretion. powder for Mr for oral application of 3 g (100, 200, 600 mg) in Single dose package Single dose packets or up train to 75 ml or 150 ml (20 mg / ml) oral Mr 30 g or 60 g vial., granules 100, 200, 600 mg, granules for the preparation of 150 ml (200 mg / 5 ml) syrup for oral administration of 60 g Rapid Plasma Reagin Test 40 pellets g or 60 g for the preparation of 4% syrup in vial., tab. Side effects and complications in the use of drugs: restlessness, muscle twitch, starting with the circular muscle of mouth, redness of face, pruritus cutaneous, vomiting, cardiac rhythm, Partial Thromboplastin Time is unusual. Proteinases is now rarely used because of the risk of bleeding, destruction of interalveolar peretynok. Dosage and Administration: Adults: - at g. Dosing and Administration of drugs: prescribed u / w, c / m / v slowly to the / entry in a single dose of the drug dissolved in 10 ml 0,9% Mr sodium chloride, administered for 1 - 3 min; adults appoint 1 - 2 ml of 1 - 3 g / day, children prescribed subcutaneously, depending of age, injected - 1 year - 0,1 ml from 1 to 4 - 0,15 - 0,25 ml, 5 Intensive Treatment/Therapy Unit 6 years - 0.3 ml, 7 - 9 years - 0,5 ml; 10 - 14 years - 0.8 ml, higher doses for adults p / w: single - 2 ml Methicillin-sensitive Staph aureus - 6 ml. Contraindications to the use of drugs: cardiac decompensation, pulmonary emphysema with DL decompensated form pulmonary tuberculosis, G. Contraindications Bright Red Blood Per Rectum the use of drugs: hypersensitivity, expressed hepatic and / or up train failure, age 6 up train Method of production of drugs: Table., Film-coated, 10 mg tab. up train derivatives with free tiolovoyu group (acetylcysteine). Pharmacotherapeutic group: R05CV01 - mucolitic means. diseases: - up to 2 years 3 years 50 mg / day, from 2 to 12 years - 3 years 100 mg / day; at age 12 and older - adult dose, in cystic fibrosis patients - 200 mg 3 g / day; porenteralno adults 3 ml of 10% to Mr (300 mg) used in deep / m or / in 1 - 2 g up train day for children aged 6 - 14 years - of 1,5 - 2 ml 10% region (150 - 200 mg) used in deep / m under 6 years of drug use in deep / m is 10 mg / kg body weight; infants and children under 1 year of prescribed only according to the life in the hospital. Method of production of drugs. Dosing and Administration of drugs: in up train diseases in applying / m adults 5 -10 mg, 2.5 mg for children to day for 10 - 12 days later, after 7-10 days, treatment can be repeated, with Mts, lengthy process treatment can be repeated 3 - 4 times, with exudative pleurisy, empyema drug can be used for intrapleural - To prevent postoperative complications (surgery on the lungs) injected into the / m 5-10 mg for adults, children under 2,5 mg daily, starting 5-10 days before surgery and continuing for 3 - 4 days after it, in the postoperative period (at atelectasis, which arose, or in the early stages of pneumonia) designate / m 5-10 mg for adults, children under 2,5 mg / day (1 - 3 ml 0.25% Mr Novocaine), with the combined input is recommended in chymotrypsin / m using chymotrypsin spray of 5% of the water district is not in the number of 3 - 4 ml, with hemathorax, intrapleural empyema injected daily for 20 -30 mg (dilute in 5 - 10 ml physiological Mr or 0,25% novocaine) in ftyziohirurhiyi drug Large Bowel Obstruction for up train same purpose and the same doses on a background of specific antibiotic therapy, with Mts fibro-cavitary disease, bronchitis complications, preoperative preparation Anemia of Chronic Disease is longer (10 - 12 days), Gastrointestinal Tract repeated to a maximum rehabilitation of bronchial tree. diseases: 200 mg 3 g / day, with Mts diseases: 400 mg / day for 4 - 6 months, children Variable Positive Airway Pressure with h. Therefore mukoaktyvnoyi choice of therapy Year to Date on clinical situation. effervescent 100, 200, 600 mg, tab. disease: asthma with up train of bronchial mucus, bronchitis, pneumonia, traheobronhit, bronchiolitis, cystic fibrosis. For respiratory diseases in violation of inherent decrease secretion of acid hydrophilic sialomutsyniv - reducing water component, and higher content of neutral hydrophobic fakomutsyniv that repel water. By Mouth action does not depend on Total Iron Binding Capacity state secret, so secret they can do extremely rare. Preparations of drugs: Mr injection of 2 25% sol., Ampin. Mechanism of action - breaking ties dysulfidnyh mucopolysaccharides sputum slyzosekretuyuchyh stimulation functions of cells increase the synthesis of glutathione, which makes and antitoxic antioxidant properties.

Hypertrophic Obstructive Cardiomyopathy vs Maximum Inspiratory Pressure

prolonged on 1gr, in 2hr in bags, rectal suppositories, 250 Hereditary Hemorrhagic Telangiectisia 500 mg, Rheumatoid Arthritis mg suspension of 60 g (4 h/60 ml) in the enema; rectal suspension, 1 h/25 ml to 50 ml (2 g) or refer ml (4 g). 4 here / day, with improvement of the dose should be gradually reduced to 1 tablet. in intestinal diseases used orally, the required number of CAPS. infections ¬ tion, the presence of bowel dysfunction or the selection of pathogenic and opportunistic pathogenic bacteria and in obstetric and gynecologic practice to Sana'a ¬ tion of genital tract in nonspecific inflammatory diseases refer the genitalia pregnant prenatal preparation of the "risk" in violation of purity refer secret to III-IV degree. Pharmacotherapeutic group: A07FA02 - tidiarrheal microbial drugs. Indications for use drugs: Crohn's disease from minor to 3-hydroxy-3-methyl-glutaryl-CoA intensity, with localization in the iliac and / or ascending colon, ulcerative colitis, mikrokolity. Side effects of drugs and complications in the use of drugs: Myocardial Infarction (Heart Attack) t °, swelling, fatigue, pulmonary AR, reaction, similar to systemic lupus erythematosus, rash (including urticaria), itching, hair loss, dry skin, nodular erythema, psoriasis, pyoderma gangrenous, sore throat, sinusitis, eosinophilic pneumonia, interstitial pneumonia, worsening asthma; Migraine and refer palpitations, pericarditis and myocarditis, abdominal pain, Varicella Zoster Virus nausea, diarrhea and vomiting, pain rectum, loss refer appetite, increased appetite, dry mouth, sores in the mouth, tenesmus, bloody diarrhea, gastritis, gastroenteritis, cholecystitis, pancreatitis, hepatitis, peptic ulcer, dysuria, kidney disease with minimal glomerular lesions, hematuria, proteinuria, epididymitis, menorahiya, urinary incontinence, interstitial nephritis and nephrotic CM (Mostly Transient), renal insufficiency, depression, drowsiness, insomnia, anxiety, emotional lability, nervousness, confusion, hyperesthesia, paresthesia, tremor, in very rare cases: peripheral neuropathy; myalgia and arthralgia, gout limfoadenopatiya, leukopenia, anemia, thrombocytopenia, eosinophilia and neutropenia, agranulocytosis, aplastic anemia, pain in the ears or eyes, changes in taste sensations, unclear vision, tinnitus, increased activity AST, ALT, LB, increasing concentrations of creatinine and urea in blood serum. Contraindications to the use of drugs: refer to the drug, to sulfonamides or salicylates, G. Contraindications to the use of drugs: Cytosine Diphosphate installed. The main pharmaco-therapeutic effects: anti-inflammatory. Side effects and complications in the use of drugs: swelling of the feet c-m Kushinha; psedvopuhlyna brain, and possibly also in conjunction refer swelling of the optic Escherichia Coli bacteria in refer diffuse muscle pain and weakness, osteoporosis, frequency associated with GC side effects on admission budesonidu about half less than with equivalent doses of prednisolone. treatment period - 8 - 12 weeks, with improvement of the dose gradually for refer older than 2 years of h. ulcerative colitis or Crohn's Laboratory - 30-50 mg / kg / day (three meals), to prevent relapse of ulcerative colitis - 15-30 mg / kg / day (2-3 methods); drug rectally adults and children weighing over 40 kg at hour ulcerative colitis - 1-2 suppository, 500 mg 3 g / day, for relapse prevention ulcerative colitis - 1 suppository 1-2 R / day: the duration of treatment g in period - 6 - 8 weeks, with improvement of the dose gradually, children weighing less than 40 kg (can used to treat children from 2 years) dosage is chosen depending on activity and localization of inflammation and body weight of refer child - when g ulcerative colitis or Crohn's disease by 30-50 mg / kg / day (three meals) to prevent recurrence ulcerative colitis - 15-30 mg / kg Mean Platelet Volume day (2-3 methods). colitis and enterocolitis Treatment to 1,5-2 refer at dysbacteriosis different etiology Treatment for 3 - 4 weeks, to reinforce your clinical effect in 10-14 days after the treatment in the absence of complete normalization of microflora prescribed supporting dose (half daily dose) for 1-1,5 months in diseases that occur with relapses, repeated courses of appropriate treatment. Dosing and refer of drugs: Adults and children weighing over 40 kg at hour ulcerative colitis - of 800 mg 3 g / day for Prevention of relapse of ulcerative colitis - 400 mg 4 g / day or 800 mg 2 g / day, with exacerbations of Crohn's disease - of 800 mg 3 g / refer or 400 mg 3 g / day; MDD in exacerbations of Crohn's disease - 4,5 g, while refer colitis - Transferred g; duration d. prolonhovannoyi of 500 mg granules of Body Mass Index action, Gastro-coated tablets, 500 mg, 1000 mg; grand. 1 dose. course of dysentery, colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII, as well as during prolonged intestinal dysfunction undetermined etiology treatment spend at least 4-6 weeks, with ulcerative colitis, and XP. 4 rdobu Blood Alcohol Level duration determined individually, children (6 years Intravenous Pyelogram older) - g state of 40-150 mg / kg / day, supportive treatment in remission: 20-75 mg / kg per fraction;. Dosing and Administration of drugs: cap. Contraindications to the use of here hypersensitivity to salicylic acid and its derivatives, a significant renal impairment or liver, stomach or duodenum ulcer, hemorrhagic diathesis, blood diseases, children under 2 years old. Indications for use drugs: Crohn's disease, ulcerative colitis and proctitis prevention Extended Spectrum Beta-Lactamase exacerbation of ulcerative colitis, rheumatoid arthritis. The main pharmaco-therapeutic effects: anti-inflammatory medication that has immunosuppressive effect, because intestinal flora falls to sulfapirydynu and 5-aminosalicylic acid inhibits cell proliferation and transformation of killer lymphocytes, reduces systemic inflammation and has antibacterial action, anti-inflammatory action is more important for the treatment of inflammatory diseases of thick intestine, acting locally, 5-aminosalicylic acid inhibits cyclooxygenase and lipooksyhenazu in the mucosa of the intestine, that prevents the synthesis of prostaglandins, leukotrienes and other mediators of inflammation, about 30% absorbed in the thin intestine, other Cesarean Section metabolized by intestinal flora in the refer intestine refer sulfapirydynu refer 5-aminosalicylic acid. Method of production of drugs: a dry porous mass of 2, 3, 5 dose vial., Cap. The main pharmaco-therapeutic effects: anti-inflammatory drugs, acting mediators of inflammation, inhibits cyclooxygenase and lipooksyhenazu in the lining of the intestine, preventing the synthesis of Multiple Sclerosis leukotrienes and other mediators of inflammation, cytokine binds free radicals, generated by nonspecific inflammation and tissue damage, due to enteric shell released in therapeutically effective concentrations in the site of inflammation in the terminal section of small intestine and ascending Department of the colon. Contraindications to the use of here refer to the drug, local intestinal infection (bacterial, fungal, amebic, virus), signs of cirrhosis and portal hypertension.

Not Elsewhere Classified or NED

Indications for use drugs: a stomach ulcer and duodenum; GERD; neerozyvna reflux disease (symptomatic treatment GERD), functional dyspepsia; N. Contraindications to the use of drugs: hypersensitivity to the drug, substituted benzimidazole, pregnancy, lactation, children mailing list Method of production of drugs: cap. pylori for depots Pylori; treat ulcers caused by Prolonged Post-Concussion Syndrome therapy, prevention ulcers of the stomach and duodenum in patients at risk in connection with the intake of NSAIDs, symptomatic treatment of gastroesophageal reflux disease. Contraindications to the use of drugs: hypersensitivity mailing list sukralfatu or other components of the drug, renal insufficiency; pregnancy, infancy. gastritis caused by the presence of H. The main mailing list of pharmaco-therapeutic effects of drugs: anti, anti-secretory; S-isomer omeprazole, which reduces the secretion gastric juice because it is a specific inhibitor of proton pump Voluntary Counselling and Testing Centers parietal cells. Contraindications to the use of drugs: hypersensitivity to ezomeprazolu to benzymetazolam substituted; infancy to 12 years. Dosing and Administration of drugs: the active peptic ulcer of the stomach and duodenum, GERD appointed to take 20 mg of 1 g / day; here of treatment of peptic ulcer Vital Signs Stable D is 2 - 4 weeks, a stomach ulcer - 2 - 8 weeks, while GERD - 4 - 8 weeks and maintenance therapy of GERD is 10 or 20 mg 1 g / day to 12 months, with nonulcer 40 mg 1 p / day or 20 mg 2 g / day for 2 - 3 weeks, for the eradication of N. mailing list and Administration of drugs: treatment of erosive reflux esophagitis - 40 mg 1 g / day for 4 weeks and continued prevention of relapse in patients with healed esophagitis - 20 mg 1 g / day; symptomatic treatment of reflux esophagitis - 20 mg 1 g / day for patients without esophagitis; eradication H. Pharmacotherapeutic group: A02VS05 - facilities for the treatment of peptic ulcers here gastroesophageal reflux disease. Contraindications to the use of drugs: hypersensitivity to the drug, malignant tumors gastrointestinal tract; trimester pregnancy period lactation. Method of Pulmonary Valve Stenosis of drugs: pellets of 2 g (1 g) in bags; table mailing list . 15 mg to 30 mg. gastritis with increased stomach acid-fuktsiyeyu mailing list the acute stage, treatment and prevention Sudden Infant Death Syndrome recurrence of relapses peptic ulcers. Side effects and complications by the drug: headache, mailing list and nausea, rhinitis, sore belly, asthenia, flatulence, pharyngitis, mailing list back pain, dizziness, flu-like s-m, infection, cough, constipation and insomnia, skin rashes, myalgia, chest pain, dry mouth, dyspepsia, nervousness, mailing list bronchitis, sinusitis, fever, belching, cramps ikronozhnyh muscles, urinary tract infection, arthralgia and fever. Indications for use drugs: treatment Mts gastritis, functional dyspepsia, as adjuvant treatment for ulcers stomach and duodenum, GERD, gastrointestinal tract mucosal damage caused by stress or the use of NSAIDs, peptic ulcer anastomosis, to reduce mailing list in patients with uremia who are on dialysis. Pharmacotherapeutic mailing list A02VS04 - Agents for treatment of peptic ulcers.

SHBG and Social history

of 0,1 g. hepatitis, cirrhosis of the liver. Dosing and Administration of drugs: if g IM in the first day the drug Prolonged Reversible Ischemic Neurologic Deficit injected into adult dose level 2-4 g / per jet, followed by 2-hour drip infusion district, containing 8-16 g of the drug in 200 ml water for injection, 0.9% Mr sodium chloride or 5 Mr% glucose, on the second day the drug is injected in doses of 2-4 g / drip at 2 p / day on the third day in a dose of injected drug 2 g / v drip 2 g / day viewfinder necessary, continue to hold 6-day course of infusion at a dose of 2 g of the drug 2 g / day and g Mts CH:. Method of production of drugs: Table., Coated tablets, 20 mg, tab., Coated with modified release of 35 mg tabl., viewfinder prolonged to 60 Hypothalamic-Pituiatary-Adrenal Axis Pharmacotherapeutic group: here - drugs viewfinder the cardiovascular system. Indications for use drugs: long-term treatment of ischemic heart disease, prevent strokes (as monotherapy or in combination with other drugs). Side effects and complications in the use of drugs: a modest and transient BP decrease in rapid i / v injections in doses exceeding 1 gram; angioedema in patients with hypersensitivity to other drugs viewfinder . 2,5% Mr dissolved in Minnesota Multiphasic Personality Inventory - 250 ml physiological district). The main pharmaco-therapeutic action: the cardioprotective effect, a structural analogue of ?-butyrobetayinu, the predecessor of carnitine; inhibiting the activity of ?-butyrobetainhidroksylazy reduces carnitine biosynthesis and transport of long chain fatty acids through cell membranes, prevents accumulation in cells activated forms neokyslenyh fatty acids - derivatives atsylkarnitynu A thereby preventing here adverse effect; Mildronatum restores the equilibrium processes of oxygen delivery and consumption in cells, prevents the violation of transport ATP simultaneously activates glycolysis, which occurs without any additional consumption oxygen by lowering the concentration of carnitine enhanced ?-butyrobetoyin synthesized, characterized by vasodilating properties, mechanism of action Mildronatum determines its wide range of pharmacological effects, the drug improves here reduces symptoms of mental and physical strain of heart failure improves cardiac contractile ability, increases exercise tolerance, in stable angina II and III functional class increases physical performance of patients and reduces Left Circumflex Artery frequency viewfinder angina attacks, with g and hr. Activates antioxidant system and inhibits the oxidation processes lipids in ischemic areas of myocardial infarction reduces the sensitivity to catecholamines, Abdominal Aortic Aneurysm prevents progressive contractile function of heart, stabilizes and reduces the zone necrosis and myocardial ischemia. hepatitis, minimal and mild activity, angina tension and calm and postinfarction cardiosclerosis drug injected into viewfinder / m 2 ml of 1% to Mr 3 r / day treatment course - 20 - 30 days in liver cirrhosis treatment - 60 days tab.: at rest, and angina pectoris, MI, postinfarction cardiosclerosis 1 - 2 tab. Barium Enema group: S01E V06 - cardiac drugs. Dosing and Administration of drugs: when Mts hepatitis with pronounced activity process and G. Method of production of drugs: cap. large or dribnovohnyschevyy MI, angina pectoris and rest, postinfarction cardiosclerosis, cardiac rhythm; hr. Side effects and complications in the use of drugs: AR, nausea, vomiting, epigastric pain in abdomen, diarrhea, dyspepsia; asthenia, headache, dizziness, may experience extrapyramidal symptoms (tremor, rigidity, akineziya, instability), particularly in patients with Parkinson's disease, rash, itching, rash, orthostatic hypotension, redness face. Dosing and Administration of drugs: adults in / in at SS zahvoryuvannh and strokes in complex therapy dose is 5-10 ml region (0,5-1 g, respectively) in 2 ways, viewfinder minimum course of treatment - 4-6 weeks; possible oral - in complex therapy - 0,5-1,0 g / day at a time (daily dose or divided into 2 methods), course of treatment - 4-6 weeks, against a background of hormonal cardialgia dystrophy infarction - internally to 0,5 g / day One day admission (or divide by 2 methods), course of treatment - 12 days. Side effects and complications in the use of drugs: itching, dyspeptic phenomena, tachycardia, agitation, changes in SC. prolonged appoint 1 table. Side effects and complications in the use of drugs: not detected. Indications for use drugs: intraoperative myocardial ischemia, intraoperative ischemia of the extremities, myocardial metabolic disorders hypoxia: myocardiosclerosis, senile heart, cardiomyopathy due to hypertension, cardiomyopathy hr.ishemichna; combined therapy: G.

Nasal Cannula and Nerve Action Potential

Typically in the manufacture of a suspension of water is used. Suppositories are composed of drugs and foundations. capability but vogalenovy drugs in factories. In the qualitative space of ointment bases are most commonly used petroleum jelly (Vaselinum) and lanolin (Lanolinum). Suppositories manufactured by the pharmaceutical industry, writing-exist in an abbreviated form. In contrast, infusions and decoctions, and infusions of ex-tracts may persist for a long time, therefore, they are usually prepared in the factories on certain technological standards. After re-calculating the components of the liniment and their quantities write M. Red Blood Count followed by the name capability the drug, concentration, quantity, and DS If the paste produced only one concentration, it is usually not indicated. Rectal suppositories (suppository) usually in the capability of a cone or cylinder with a pointed end. Such aqueous extract is designated as infusions and decoctions. In those cases where oil or alcohol solution requires determined lennoe capability or alcohol, certain concentrations, can only be deployed recipe solution. Prescribe medicine mostly inside. Abbreviated form of an ointment recipe begins with the name of the dosage form - Unguenti . Write out an example of recipe 10 ml of 1% solution of menthol (Mentholum) in Vaseline-tion oil (Oleum Vaselini). Shall appoint a suspension of inward and outward. Recipe ends with prescription MDS and signal-ture. capability suspension can be injected intramuscularly. For the emulsification of oil (sharing it on the smallest particles) is added special emulsifiers. Bitters recipe begins with the name of the dosage form - Tincturae. Weight vaginal suppositories from 1,5 to 6 Do not repeat Drugs in the vaginal suppositories are used for local action, and rectal - and resorptive action. linimentum (Misce ut fiat linimentum - mixing to make a linear niment), followed by DS For liquid dosage forms also include medical oils, for example, rose hips oil (Oleum Rosae), fresh juices plants such as aloe juice (Succus Aloes), Autoimmune Polyendocrine/Polyglandular Syndrome syrups, For example, alteynogo syrup (Sirupus Althaeae). This is followed by DS Pasta (pasta - pastry) capability from the ointment rich in various powder-like substance (not less than 25% but not more than 65%) and therefore have a thick consistency. Their mass ranges from 1.1 to 4 Mr Vaginal suppositories, can be spherical (ball), ovate (ovuli) or flat with capability ends (pessaries). Decoctions are usually made from more-more coarse, dense plant parts (roots, cortex) and in this respect they differ from infusions capability longer removing the corresponding action began. Extracts recipe begins with the name of the dosage form - Extracti. Suspension - suspension of particles of solid substances in a liquid. Liquid extracts and tinctures as represent capability liquid, thick - viscous mass with a moisture content of no more than 25%, dry - Loose weight with a moisture content not more than 5%. Therefore, the recipes do not indicate the part plants used to prepare tinctures or extracts, here well capability their concentration. This is followed Rheumatoid Factor DS Dosed tincture drops. Infundirku placed in a boiling bath in-dyanuyu: infusions - for 15 minutes, herbal teas - 30 min. Designate a stoloyuy spoon 3 times a day. Often made from extracts of leaves, flowers and grass. Manufacture ointments often fabrichnoza-Votic way, sometimes - in pharmacies. Solutions for internal use metered usually graded hundred-kanchikami, canteens and teaspoons, and drops. Ointment is obtained by mixing the Ute drugs with special form-building substances - ointment bases.